The Medicines and Medical Devices Bill, which could increase the range of professions able to prescribe medicines in low risk circumstances, will have a second reading in the House of Commons on March 2.
An explanatory note, which is not part of the bill, says that regulations made under clause 1(1) of the Bill could be used to allow additional healthcare professionals, including pharmacists, to be given appropriately restricted prescribing rights, or to amend the exemptions to the requirement for a prescription.
An impact assessment explains that, essentially, the bill gives the government the powers to update the regulatory schemes for human medicines, clinical trials of human medicines, and veterinary medicines through secondary legislation once the Brexit transition period is complete and EU legislation no longer applies.
The Pharmacy Law and Ethics Association said that examples of changes to the current law that are suggested in the explanatory note include:
This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.
We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.